^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in combination with hydrocortisone sodium succinate (Upjohn) 100 mg/L in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

^d Given over three minutes into a heparin infusion run at 1 mL/min.

^e Tested in dextrose 5% in Ringer’s injection, dextrose 5% in Ringer’s injection, lactated, dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.

^f Tested in both dextrose 5% and sodium chloride 0.9%.

^g Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.

^h Dacarbazine in intravenous tubing flushed with heparin sodium.

ⁱ Injected over one minute.

^j Tested in sterile water for injection.

^k Tested in Ringer’s injection, lactated.

^l Final concentration after mixing.

^m Tested in dextrose 5% in Ringer’s injection, lactated, dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.

ⁿ Lyophilized formulation tested.

^o Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^p Tested in dextrose 5% in Ringer’s injection.

^q Test performed using the formulation WITHOUT edetate disodium.

^r Tested with albumin human 0.1%.

^s Tested in dextrose 5% in sodium chloride 0.225%.

^t Tested in sodium chloride 0.45%.

^u Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.

^v Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^w Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^x Test performed using the Cubicin formulation.

^y Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^z Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^aa Tested in both dextrose 5% and Ringer’s injection, lactated.

^bb Run at 1000 units/hr.

^cc Test performed using the formulation WITH edetate disodium.

^dd Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^ee Salt not specified.

^ff Tested in dextrose 10%.

^gg Tested as the premixed infusion solution.

^hh Tested with epinephrine (PAR) 16 mcg/mL in dextrose 5%.

ⁱⁱ Tested with epinephrine (PAR) 64 mcg/mL in dextrose 5%.

^jj Tested with calcium chloride (IMS) 100 mg/mL.

^kk Tested with calcium chloride (IMS) 20 mg/mL in dextrose 5%.

^ll Tested with milrinone lactate (HIK) 200 mcg/mL in dextrose 5%.

^mm Tested with milrinone lactate (HIK) 400 mcg/mL in dextrose 5%.

ⁿⁿ Tested with vasopressin (PAR) 0.2 unit/mL in dextrose 5%.

^oo Tested with vasopressin (PAR) 1 unit/mL in dextrose 5%.

^pp Run at 0.72 mL/hr.

^qq Run at 0.36 mL/hr.

^rr Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.

^ss Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^tt Intralipid product.

^uu SMOFlipid product.